KORU Medical Systems Inc (KRMD)

Currency in USD
2.965
-0.055(-1.82%)
Real-time Data·
KRMD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.9453.255
52 wk Range
2.8606.608
Key Statistics
Prev. Close
3.02
Open
3.05
Day's Range
2.945-3.255
52 wk Range
2.86-6.608
Volume
95.86K
Average Volume (3m)
228.16K
1-Year Change
-21.5608%
Book Value / Share
0.39
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
KRMD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6.250
Upside
+110.79%
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations

KORU Medical Systems Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Analyst Ratings

3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 6.250
(+110.79% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
B.Riley
Buy8.00+169.81%7.00Maintain13-03-2026
Piper Sandler
Hold5.00+68.63%4.00Maintain20-01-2026
Craig-Hallum
Buy7.00+136.09%6.25Maintain13-01-2026
Lake Street Capital Markets
Buy8.00+169.81%6.00Maintain22-12-2025
Canaccord Genuity
Buy6.00+102.36%5.00Maintain17-12-2025

KORU Medical Systems Inc Earnings Call Summary for Q2/2026

  • KORU Medical posted Q2 2026 revenue of $12M (up 18% YoY), beating estimates of $11.62M, but shares fell 7.51% after hours on lowered guidance.
  • Company reported first positive net income since 2019; gross margin improved to 65.1% from 63.5%, with adjusted EBITDA of $900K in H1 2026.
  • Full-year 2026 revenue guidance narrowed to $47.5M-$48.5M, below prior outlook, citing slower international market timing in non-tender regions.
  • International core revenue surged 59% to $3.5M while domestic core grew 12% to $8M; Pharma Services revenue fell 35% on lower clinical trial orders.
  • CEO emphasized digital transformation strategy; company expects year-end cash above $7.5M and raised gross margin guidance to 62%-64% from 61%-63%.
Last Updated: 06-08-2026, 02:56 am
Read Full Transcript

Earnings

Latest Release
05-08-2026
EPS / Forecast
0.02 / -0.02
Revenue / Forecast
12M / 11.62M
EPS Revisions
Last 90 days

KRMD Income Statement

Compare KRMD to Peers and Sector

Metrics to compare
KRMD
Peers
Sector
Relationship
P/E Ratio
−76.0x−2.7x−0.4x
PEG Ratio
−1.29−0.150.00
Price/Book
7.7x2.5x2.6x
Price / LTM Sales
3.1x2.2x3.0x
Upside (Analyst Target)
107.0%139.8%56.4%
Fair Value Upside
Unlock4.7%7.9%Unlock

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
5.89M12.75%17.25M
Other Institutional Investors
28.88M62.54%84.61M
Public Companies & Retail Investors
11.41M24.71%33.43M
Total
46.17M100.00%135.28M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Horton Capital Management, LLC10.98%50,69,54114,854
Horton Capital Partners Fund, L.P.10.98%50,69,54114,854

FAQ

What Is the KORU Medical Systems (KRMD) Share Price Today?

The KORU Medical Systems share price today is 2.965.

What is the current KORU Medical Systems (KRMD) share price and day range?

As of 02-10-2026, the KORU Medical Systems share price is 2.965, with a previous close of 3.020. The share price has ranged from 2.945 to 3.255 today, while the 52-week range spans from 2.860 to 6.608.

What Is the KORU Medical Systems Market Cap?

As of today, KORU Medical Systems market cap is 139.440M.

What Is the KORU Medical Systems (KRMD) Share Price Target?

The average 12-month share price target for KORU Medical Systems is 6.250, with a high estimate of 8 and a low estimate of 5. 3 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +110.79% Upside potential.

What Is KORU Medical Systems's Earnings Per Share (TTM)?

The KORU Medical Systems EPS (TTM) is -0.040.

When Is the Next KORU Medical Systems Earnings Date?

KORU Medical Systems will release its next earnings report on 11-11-2026.

From a Technical Analysis Perspective, Is KRMD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

What Stock Exchange Does KORU Medical Systems Trade On?

KORU Medical Systems is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for KORU Medical Systems?

The stock symbol for KORU Medical Systems is "KRMD."

How Many Times Has KORU Medical Systems Stock Split?

KORU Medical Systems has split 0 times.

How Many Employees Does KORU Medical Systems Have?

KORU Medical Systems has 73 employees.

What Is the KRMD After Hours Price?

KRMD's last after hours stock price is 2.960, the stock has changed by -0.060, or -1.990%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.